The efficacy of terazosin in the management of chronic pelvic pain syndrome (CPPS): Comparison between category IIIa and IIIb

Korean Journal of Urology

Volumn 47, Issue 11, 2006, Pages 1191-1196

  Jung, Yon Hwan ^a   Kim, Jong Gu ^a   Cho, In Rae ^a  

^a Inje University   (South Korea)

Author keywords

Pelvic pain; Prostatitis; Syndrome; Terazosin

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; HYTRINE; KLIMAIN; LEVOFLOXACIN; TALMIFLUNATE; TERAZOSIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; PAIN ASSESSMENT; PELVIS PAIN SYNDROME; PROSTATITIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TRANSRECTAL ULTRASONOGRAPHY; URINALYSIS; UROFLOWMETRY;

EID: 33846926604     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.11.1191     Document Type: Article

References (22)

1. Nickel JC. Prostatitis: myths and realities. Urology 1998;51: 362-6
2. Cho IR. Evaluation and treatment of patients with prostatitis. Korean J Androl 2005;20:1-11
3. Cho IR, Park SC, Park SS. The prevalence of the symptoms of the prostate syndrome patients under 50. Korean J Urol 1998;39:751-6
4. Wenninger K, Heiman JR, Rothman I, Berghuis JP, Berger RE. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol 1996;155:965-8
5. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999;282:236-7
6. Schaeffer AJ, Datta NS, Fowler JE Jr, Krieger JN, Litwin MS, Nadler RB, et al. Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology 2002;60(Suppl 6):1-4
7. Donker PJ, Ivanovici F, Noach EL. Analyses of the urethral pressure profile by means of electromyography and the administration of drugs. Br J Urol 1972;44:180-93
8. Mehik A, Hellstrom P, Lukkarinen O, Sarpola A, Alfthan O. Increased intraprostatic pressure in patients with chronic prostatitis. Urol Res 1999;27:277-9
9. Mehik A, Helstrom P, Nickel JC, Kilponen A, Leskinen M, Sarpola A, et al. The chronic prostatitis-chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements. J Urol 2002;167:137-40
10. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968;5:492-518
11. Nickel JC, Pontari M, Moon T, Gittleman M, Malek G, Farrington J, et al. A randomized placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 2003;169: 1401-5
12. Datta NS. Role of alpha-blockers in the treatment of chronic prostatitis. Urology 2002;69(Suppl 6):27-8
13. Barbalias GA, Nikiforidis G, Liatsikos EN. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 1998;159:883-7
14. Barbalias GA. Why alpha-blockers in prostatitis? Eur Urol 2003;60:27-9
15. de la Rosette JJ, Karthaus HF, van Kerrebroeck PE, de Boo T, Debruyne FM. Research in 'prostatitis syndrome': the use of alfuzocin (a new alpha 1-receptor-blocking agents) in patients mainly presenting with micturition complaints of an irritative nature and confirmed urodynamic abnormalities. Eur Urol 1992;22:222-7
16. Mehik A, Alas P, Nickel JC, Sarpola A, Helstrom PJ. Alfuzosin treatment for chronic prostatitis-chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 2003;62:425-9
17. Kim SJ, Ha JS, Lee SJ, Cho YH, Yoon MS. Clinical effect of tamsulosin in noninflammatory chronic pelvic pain syndrome. Korean J Urol 2003;44:120-3
18. Nickel JC, Narayan P, McKay J, Doyle C. Treatment of chronic prostatitis/ chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 2004;171:1594-7
19. Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O'leary MP, et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis-chronic pelvic pain syndrome. Ann Intern Med 2004;141:581-9
20. Neal DE Jr, Moon TD. Use of terazocin in prostatodynia and validation of a symptom score questionnaire. Urology 1994;43: 460-5
21. Gul O, Eroglu M, Ozok U. Use of terazosin in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index. Int Urol Nephrol 2001;32:433-6
22. Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, et al. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol 2003;169:592-6